Pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6, are critical drivers in the development of diabetic neuropathy, but chemokines and anti-inflammatory cytokines also play a substantial role in modulating the disease. Here, TNF is linked to diabetic neuropathy.